The Swedish government has chosen to focus strategic investments on three key areas: medicine and bioscience, technology, and climate.
Sweden is particularly strong in biotechnology. Pharmaceuticals are a key export, and Swedish medical innovations include the asthma medicines Bricanyl and Pulmicort; the growth hormone Genotropin; and the stomach ulcer drug Losec, one of the world’s best-selling drugs.